Our latest news
What We’re Working On
Media Contact
Dan Budwick
dan@1abmedia.com
Bringing Meaningful Therapies from One to Many
-
September 25th, 2024
Actio Biosciences to Participate in Upcoming October Investor Conferences
Read More -
August 20th, 2024
Actio Biosciences Appoints Dimitrios Arkilo, M.D., Experienced Neurologist and Epileptologist, as Chief Medical Officer
Read More -
August 8th, 2024
Actio Biosciences Receives Orphan Drug and Rare Pediatric Disease Designations for the Treatment of Charcot-Marie-Tooth Disease 2C
Read More -
July 16th, 2024
Renowned Rare-Disease Drug Developer Emil Kakkis, M.D., Ph.D., to Join Actio Biosciences Board of Directors
Read More -
May 22nd, 2024
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
Read More